Language
English
Publication Date
10-15-2025
Journal
Journal of Clinical Investigation
DOI
10.1172/JCI191824
PMID
40773289
PMCID
PMC12520667
PubMedCentral® Posted Date
8-7-2025
PubMedCentral® Full Text Version
Post-print
Keywords
Genetic diseases, Genetics, Potassium channels, Pulmonology, Therapeutics
Published Open-Access
yes
Recommended Citation
Baumlin, Nathalie; Gunewardena, Sumedha; Randell, Scott H; et al., "Differential Bk Channel Potentiation by Vanzacaftor Enantiomers Enables Therapy for Modulator-Ineligible People With Cystic Fibrosis" (2025). Faculty and Staff Publications. 3979.
https://digitalcommons.library.tmc.edu/baylor_docs/3979